Aerovate Therapeutics scoops up $72.6m Series A
Aerovate Therapeutics Inc, a biotech company, has raised $72.6 million in Series A funding.
Aerovate Therapeutics Inc, a biotech company, has raised $72.6 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination